Immune and inflammatory mechanisms in the development of atherosclerosis.
about
ApoE production in human monocytes and its regulation by inflammatory cytokinesInsights into the monomers and single drugs of Chinese herbal medicine on myocardial preservationEffects of local cytochalasin D delivery on smooth muscle cell migration and on collar-induced intimal hyperplasia in the rabbit carotid arteryT lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein.GTP cyclohydrolase I gene polymorphisms are associated with endothelial dysfunction and oxidative stress in patients with type 2 diabetes mellitus.Inflammation, immunity, and hypertension.Inflammatory therapeutic targets in coronary atherosclerosis-from molecular biology to clinical application.CCL5/RANTES gene polymorphisms in Slavonic patients with myocardial infarctionActivation of novel estrogen receptor GPER results in inhibition of cardiocyte apoptosis and cardioprotection.Linking immunity to atherosclerosis: implications for vascular pharmacology--a tribute to Göran K. Hansson.The investigation of serum vaspin level in atherosclerotic coronary artery disease.Triptolide inhibits the progression of atherosclerosis in apolipoprotein E-/- mice.Innate immune signaling in cardiac ischemia.Targeting the adaptive immune system: new strategies in the treatment of atherosclerosis.Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient miceEfficacy of different doses of aspirin in decreasing blood levels of inflammatory markers in patients with cardiovascular metabolic syndrome.Atherogenic effect of interleukin-2 and antiatherogenic effect of interleukin-2 antibody in apo-E-deficient mice.Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease.
P2860
Q21559536-7A4B259C-9C60-4BAC-A728-366BD364C851Q26864653-20575FAA-5D0E-4621-BE39-28591809E33AQ28361022-EB91B1A1-1BAD-4D2C-B194-572DCB146385Q34390132-BC8B81DF-E778-4F12-BBBD-2A4DD6B0A09FQ34450063-C7989A79-8009-4EFC-B973-C5153BAD09EAQ34528283-52890D19-94BE-47DA-B080-328E715E5613Q34554918-7375F6D8-6511-4CE8-85B9-505194DC6550Q34909073-5D1316CB-F550-4B61-BF02-3134C4A81D29Q35621108-7F84B95E-35CE-4182-BFA2-C9291803298DQ35713532-384F62D0-55B1-47BA-9573-5D027B2B5A2CQ35872485-670458CE-4A8B-4E4C-860F-E83AA919EEDAQ37288251-AB115B11-1278-4D79-9388-5651EC0023C2Q37859249-7277916F-8042-44FC-BAFF-C0E2A4100C0DQ38406177-61DB7BDE-D1BE-4EAF-A0F6-391D3A9A1898Q42803118-AAA91473-F531-48DC-8294-8F133A84BEA1Q43244897-A723F4BA-66B5-4489-80E5-C8506DAE71C6Q47446212-B2801159-97FB-4FB4-82B2-9012EA41541FQ48006325-6CE94460-0E8A-4F27-B7A3-7B8625CE8C61
P2860
Immune and inflammatory mechanisms in the development of atherosclerosis.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Immune and inflammatory mechanisms in the development of atherosclerosis.
@en
type
label
Immune and inflammatory mechanisms in the development of atherosclerosis.
@en
prefLabel
Immune and inflammatory mechanisms in the development of atherosclerosis.
@en
P2860
P1476
Immune and inflammatory mechanisms in the development of atherosclerosis.
@en
P2093
Hansson GK
P2860
P304
P356
10.1136/HRT.69.1_SUPPL.S38
P433
P577
1993-01-01T00:00:00Z